FOLH1 and neoplasm: Tumor activity uptake of 111In-6 dropped by only 25%–30% when the targeted receptors were blocked individually, modeling a situation with PSMA-positive/GRPR-negative and PSMA-negative/GRPR-positive xenografts used in other published studies.